DARLING INGREDIENTS INC. (DAR) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-07-04..
- Stock-based compensation / revenue · 12 months: Value 0.56%; Formula and calculation Share-based compensation / revenue. Period ending 2026-07-04..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-07-04; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-07-04. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.56% | Share-based compensation / revenue. Period ending 2026-07-04. $36.65M ÷ $6.55B × 100 ≈ 0.56% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 6.55B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 36.65M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 951.18M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-04 | (m) | $6.55B | $36.65M | $951.18M | (m) | (m) | 0.56% | (m) | (m) |
| 2026-04-04 | (m) | $6.31B | $32.67M | $471.81M | (m) | (m) | 0.52% | (m) | (m) |
| 2026-01-03 | (m) | $6.14B | $21.80M | $273.44M | (m) | (m) | 0.36% | (m) | (m) |
| 2025-09-27 | (m) | $5.84B | $6.05M | $298.43M | (m) | (m) | 0.10% | (m) | (m) |
| 2025-06-28 | (m) | $5.70B | $-1.02M | $286.81M | (m) | (m) | -0.02% | (m) | (m) |
| 2025-03-29 | (m) | $5.68B | $5.15M | $359.45M | (m) | (m) | 0.09% | (m) | (m) |
| 2024-12-28 | (m) | $5.72B | $20.92M | $468.22M | (m) | (m) | 0.37% | (m) | (m) |
| 2024-09-28 | (m) | $5.91B | $30.89M | $504.61M | (m) | (m) | 0.52% | (m) | (m) |
| 2024-06-29 | (m) | $6.11B | $38.66M | $622.87M | (m) | (m) | 0.63% | (m) | (m) |
| 2024-03-30 | (m) | $6.42B | $34.14M | $831.05M | (m) | (m) | 0.53% | (m) | (m) |
| 2023-12-30 | (m) | $6.79B | $33.16M | $949.73M | $259.22M | (m) | 0.49% | 3.66× | Reported |
| 2023-09-30 | (m) | $6.94B | $33.17M | $1.04B | (m) | (m) | 0.48% | (m) | (m) |
| 2023-07-01 | (m) | $7.06B | $29.72M | $1.13B | (m) | (m) | 0.42% | (m) | (m) |
| 2023-04-01 | (m) | $6.96B | $30.54M | $1.05B | (m) | (m) | 0.44% | (m) | (m) |
| 2022-12-31 | (m) | $6.53B | $25.00M | $1.03B | $125.57M | (m) | 0.38% | 8.20× | Reported |
| 2022-10-01 | (m) | $6.07B | $22.31M | $990.88M | (m) | (m) | 0.37% | (m) | (m) |
| 2022-07-02 | (m) | $5.51B | $21.20M | $928.21M | (m) | (m) | 0.38% | (m) | (m) |
| 2022-04-02 | (m) | $5.06B | $19.75M | $917.86M | (m) | (m) | 0.39% | (m) | (m) |
| 2022-01-01 | (m) | $4.74B | $21.84M | $884.47M | $62.08M | (m) | 0.46% | 14.25× | Reported |
| 2021-10-02 | (m) | $4.45B | $22.43M | $747.80M | (m) | (m) | 0.50% | (m) | (m) |
| 2021-07-03 | (m) | $4.12B | $21.67M | $669.59M | (m) | (m) | 0.53% | (m) | (m) |
| 2021-04-03 | (m) | $3.77B | $20.82M | $507.62M | (m) | (m) | 0.55% | (m) | (m) |
| 2021-01-02 | (m) | $3.57B | $23.22M | $430.94M | $72.69M | (m) | 0.65% | 5.93× | Reported |
| 2020-09-26 | (m) | $3.41B | $21.67M | $649.86M | (m) | (m) | 0.64% | (m) | (m) |
| 2020-06-27 | (m) | $3.40B | $22.39M | $582.26M | (m) | (m) | 0.66% | (m) | (m) |
| 2020-03-28 | (m) | $3.38B | $21.50M | $550.10M | (m) | (m) | 0.64% | (m) | (m) |
| 2019-12-28 | (m) | $3.36B | $21.01M | $475.82M | $78.67M | (m) | 0.62% | 6.05× | Reported |
| 2019-09-28 | (m) | $3.36B | $23.72M | $96.49M | (m) | (m) | 0.71% | (m) | (m) |
| 2019-06-29 | (m) | $3.33B | $19.73M | $102.11M | (m) | (m) | 0.59% | (m) | (m) |
| 2019-03-30 | (m) | $3.35B | $20.11M | $87.74M | (m) | (m) | 0.60% | (m) | (m) |
| 2018-12-29 | (m) | $3.39B | $18.78M | $95.22M | $86.43M | (m) | 0.55% | 1.10× | Reported |
| 2018-09-29 | (m) | $3.49B | $16.49M | $103.35M | (m) | (m) | 0.47% | (m) | (m) |
| 2018-06-30 | (m) | $3.61B | $19.83M | $119.56M | (m) | (m) | 0.55% | (m) | (m) |
| 2018-03-31 | (m) | $3.66B | $19.86M | $136.06M | $90.37M | (m) | 0.54% | 1.51× | Reported |
| 2017-12-30 | (m) | $3.66B | $17.60M | $136.81M | $88.93M | (m) | 0.48% | 1.54× | Reported |
| 2017-09-30 | (m) | $3.60B | $17.09M | $137.17M | $89.10M | (m) | 0.47% | 1.54× | Reported |
| 2017-07-01 | (m) | $3.52B | $16.27M | $139.38M | $90.43M | (m) | 0.46% | 1.54× | Reported |
| 2017-04-01 | (m) | $3.50B | $14.62M | $156.79M | $91.97M | (m) | 0.42% | 1.70× | Reported |
| 2016-12-31 | (m) | $3.40B | $10.33M | $152.07M | $94.19M | (m) | 0.30% | 1.61× | Reported |
| 2016-10-01 | (m) | $3.32B | $10.48M | $149.41M | $95.06M | (m) | 0.32% | 1.57× | Reported |
| 2016-07-02 | (m) | $3.32B | $9.42M | $152.69M | $96.02M | (m) | 0.28% | 1.59× | Reported |
| 2016-04-02 | (m) | $3.30B | $10.15M | $137.51M | $106.32M | (m) | 0.31% | 1.29× | Reported |
| 2016-01-02 | (m) | $3.40B | $8.99M | $142.64M | $105.53M | (m) | 0.26% | 1.35× | Reported |
| 2015-10-03 | (m) | $3.59B | $10.65M | $149.59M | $106.86M | (m) | 0.30% | 1.40× | Reported |
| 2015-07-04 | (m) | $3.71B | $10.87M | $160.70M | $107.38M | (m) | 0.29% | 1.50× | Reported |
| 2015-04-04 | (m) | $3.88B | $13.63M | $196.90M | $99.67M | (m) | 0.35% | 1.98× | Reported |
| 2015-01-03 | (m) | $3.96B | $20.81M | $164.51M | $135.42M | (m) | 0.53% | 1.21× | Reported |
| 2014-09-27 | (m) | $3.32B | $18.67M | $143.38M | $132.28M | (m) | 0.56% | 1.08× | Reported |
| 2014-06-28 | (m) | $2.79B | $19.14M | $135.11M | $112.24M | (m) | 0.69% | 1.20× | Reported |
| 2014-03-29 | (m) | $2.21B | $15.01M | $110.43M | $91.34M | (m) | 0.68% | 1.21× | Reported |
| 2013-12-28 | (m) | $1.72B | $9.43M | $169.57M | $38.11M | (m) | 0.55% | 4.45× | Reported |
| 2013-09-28 | (m) | $1.72B | $8.89M | $200.52M | $22.11M | (m) | 0.52% | 9.07× | Reported |
| 2013-06-29 | (m) | $1.75B | $8.85M | $224.64M | $22.67M | (m) | 0.51% | 9.91× | Reported |
| 2013-03-30 | (m) | $1.76B | $8.72M | $237.81M | $22.75M | (m) | 0.50% | 10.45× | Reported |
| 2012-12-29 | (m) | $1.70B | $8.90M | $231.74M | $24.05M | (m) | 0.52% | 9.63× | Reported |
| 2012-09-29 | (m) | $1.71B | $8.26M | $241.88M | $26.33M | (m) | 0.48% | 9.19× | Reported |
| 2012-06-30 | (m) | $1.71B | $6.65M | $250.65M | $27.87M | (m) | 0.39% | 8.99× | Reported |
| 2012-03-31 | (m) | $1.74B | $5.79M | $278.94M | $29.86M | (m) | 0.33% | 9.34× | Reported |
| 2011-12-31 | (m) | $1.80B | $3.93M | $314.61M | $37.16M | (m) | 0.22% | 8.47× | Reported |
| 2011-10-01 | (m) | $1.59B | $4.09M | $279.83M | $35.46M | (m) | 0.26% | 7.89× | Reported |
| 2011-07-02 | (m) | $1.31B | $3.51M | $224.38M | $28.91M | (m) | 0.27% | 7.76× | Reported |
| 2011-04-02 | (m) | $1.00B | $2.81M | $151.06M | $22.05M | (m) | 0.28% | 6.85× | Reported |
| 2011-01-01 | (m) | $724.91M | $2.15M | $82.51M | $8.74M | (m) | 0.30% | 9.44× | Reported |
| 2010-10-02 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-07-03 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-04-03 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-01-02 | (m) | $597.81M | $768.00K | $70.94M | $3.10M | (m) | 0.13% | 22.85× | Reported |
| 2009-10-03 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-07-04 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-01-03 | (m) | $807.49M | $800.00K | $92.68M | $3.02M | (m) | 0.10% | 30.71× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bunge Global SA (BG) | Switzerland | $21.391B | 36.03 |
| Archer-Daniels-Midland Co (ADM) | United States | $39.458B | 20.81 |